TrialFind
Saved trials
Back to results
Completed
Phase 2
Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease
NCT00224263
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Xuanwu Hospital
Beijing, China
View on ClinicalTrials.gov
Official details
Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease — TrialFind